Relationship between abdominal obesity and other cardiovascular risk factors: Cross sectional study of patients with symptomatic carotid disease

Srpski Arhiv za Celokupno Lekarstvo

Volumn 141, Issue 7-8, 2013, Pages 460-465

  Maksimović, Miloš ^a   Vlajinac, Hristina ^a   Radak, Djordje ^a,b   Marinković, Jelena ^a   Maksimović, Jadranka ^a   Jorga, Jagoda ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Epidemiology School of Medicine University of Belgrade ^*  (Serbia)

Author keywords

Abdominal obesity; Carotid disease; Risk factors

Indexed keywords

CAROTID ARTERY DISEASES; COMPLICATION; CROSS-SECTIONAL STUDY; HUMAN; OBESITY, ABDOMINAL; RISK FACTOR;

CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; OBESITY, ABDOMINAL; RISK FACTORS;

EID: 84906856288     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1308460M     Document Type: Article

References (43)

1. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005; 352:1138-48.
2. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation. Part 1: Diabetes mellitus - Diagnosis. 2006.
3. Republic of Serbia, Ministry of Health. National Health Survey, Serbia 2006 - Key Findings. Belgrade: Ministry of Health; 2006.
4. Levitan EB, Yang AZ, Wolk A, Mittleman MA. Adiposity and incidence of heart failure hospitalization and mortality: A population based prospective study. Circ Heart Fail. 2009; 2:202-8.
5. Park JW, Lee SY, Kim SY, Choe H, Jee SH. BMI and stroke risk in Korean women. Obesity (Silver Spring). 2008; 16:396-401.
6. Lear SA, Humphries KH, Kohli S, Frohlich JJ, Birmingham CL, Mancini GB. Visceral adipose tissue, a potential risk factor for carotid atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-CHAT). Stroke. 2007; 38:2422-9.
7. Burke GL, Bertoni G, Shea S, Tracy R, Watson K, Blumenthal RS, et al. The impact of obesity on cardiovascular risk factors on subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008; 168:928-35.
8. Jansen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002; 162:2074-9.
9. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007; 116:2933-43.
10. Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of Carotid Endarectomy in Patients with Symptomatic Moderate or Severe Stenosis. N Engl J Med. 1998; 339:1415-25.
11. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva: WHO; 1998.
12. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206-52.
13. Centers for Disease Control/American Heart Association Workshop on Inflammatory Markers, and ardiovascular Disease: application to clinical and public health practice: Atlanta, March 14-15, 2002. Atlanta, GA: Centers for Disease Control and Prevention; 2002.
14. Third report of the National Cholesterol Education Program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment panel III). Final report. Circulation. 2002; 106:3143-421.
15. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R; Third National Health and Nutrition Examination Survey. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27:2954-9.
16. Baecke JA, Burema HJ, Fritjers JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982; 36:932-42.
17. Allison PD. Logistic Regression Using SAS: Theory and Application. 8th ed. Cary, NC: SAS Institute, Inc.; 2009. p.50.
18. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006; 444:875-80.
19. Garg A, Misra A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol Metab Clin Orth Am. 2004; 33:305-31.
20. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus? Nature Genet. 2000; 26(1):13.
21. Després JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006; 38:52-63.
22. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444:881-7.
23. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008; 28:1039-49.
24. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002; 51:144-51.
25. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002; 277:50230-6.
26. Holst D, Grimaldi PA. New factors in the regulation of adipose tissue differentiation and metabolism. Curr Opin Lipidol. 2002; 13:241-6.
27. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998; 83:847-50.
28. Miranda PJ, DeFronzo RA, Califf R M, Guyton JR Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J. 2005; 149:33-45.
29. Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology. 1999; 10:391-7.
30. Lehto S, Niskanen L, Rönnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998; 29:635-9.
31. Langlois M, De Bacquer D, Duprez D, De Buyzere M, Delanghe J, Blaton V. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis. 2003; 68:163-8.
32. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and metaanalysis. Arthritis Rheum. 2009; 61:885-92.
33. Loenen HM, Eshius H, Lowik MR, Schouten EG, Hulshof KF, Odink J, et al. Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System). J Clin Epidemiol. 1990; 43:1297-303.
34. Oyama C, Takahashi T, Oyamada M, Oyamada T, Ohno T, Miyashita M, et al. Serum uric acid as an obesity-related indicator in early adolescence. Tohoku J Exp Med. 2006; 209:257-62.
35. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sar I. Serum Uric Acid is a determinant of metabolic syndrome in a populationbased study. Am J Hypertens. 2006; 19:1055-62.
36. Sadr SM, Namayandeh SM, Moadares MM, Rafiei M. Serum uric acid levels and its association with cardiovascular risk factors. Iranian J Publ Health. 2009; 38:53-9.
37. Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res. 2004; 27:227-33.
38. Numata T, Miyatake N, Wadab J, Makinob H. Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. Diabetes Res Clin Pract. 2008; 80(1):e1-e5.
39. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008; 57:845-52.
40. Dehghan A, Van Hoek M, Sijbrands EJG, Hofman A, Witteman JCM. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008; 31:361-2.
41. Ishizaka N, Ishizaka Y, Toda E, Nagai R,Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005; 25:1038-44.
42. Hajian-Tilaki KO. Association of educational level with risk of obesity and abdominal obesity in Iranian adults. J Pub Health. 2010; 32:202-9.
43. Boissonnet C, Schargrodsky H, Pellegrini F, Machhia A, Champagne BM, Wilson E, et al. Educational inequalities in obesity, abdominal obesity, and metabolic syndrome in seven Latin American cities: the CARMELA Study. Eur J Cardiovasc Prev Rehabil. 2011; 18:550-6.